By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences today announced Michael Hunkapiller is replacing Hugh Martin as the company's president and CEO, effective immediately.

Martin will remain on the company's board of directors through its next annual meeting of shareholders and has agreed to resign from the board on the date of the meeting. He will serve as a consultant to PacBio for six months, it said in a document filed with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.